Bionano Genomics Inc (BNGO)
0.4632
+0.02
(+4.94%)
USD |
NASDAQ |
Sep 27, 16:00
0.4726
+0.01
(+2.03%)
Pre-Market: 20:00
Bionano Genomics Research and Development Expense (Annual): 54.03M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 54.03M |
| December 31, 2022 | 49.05M |
| December 31, 2021 | 22.48M |
| December 31, 2020 | 10.26M |
| Date | Value |
|---|---|
| December 31, 2019 | 9.081M |
| December 31, 2018 | 9.484M |
| December 31, 2017 | 12.01M |
| December 31, 2016 | 11.43M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
9.081M
Minimum
2019
54.03M
Maximum
2023
28.98M
Average
22.48M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Revvity Inc | 216.58M |
| Bruker Corp | 294.80M |
| Azenta Inc | 33.96M |
| Harvard Bioscience Inc | 11.76M |
| Akoya Biosciences Inc | 21.89M |